Every Form 4 that Life360 Inc (LIF) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A Form 4 covers the transactions officers, directors and large holders report, so if you follow LIF and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full LIF filings page.
Life360, Inc. director Charles J. Prober exercised stock options for 7,930 shares of common stock at an exercise price of $11.18 per share on February 13, 2026, then sold 7,930 shares in open-market transactions at an average price of $49.02 per share under a pre-arranged Rule 10b5-1 trading plan adopted on March 14, 2025. Following these transactions, he directly holds 105,456 shares of common stock, including 1,357 restricted stock units that each convert into one share upon vesting, and retains 71,370 stock options subject to the vesting schedule described.
Life360, Inc. Chief Financial Officer Russell John Burke reported an option exercise and updated share holdings. On 01/14/2026, he exercised a stock option to acquire 12,427 shares of common stock at $3.58 per share, bringing his directly held common stock (including awards) to 84,657 shares. This direct position includes 72,230 restricted stock units, each representing a contingent right to one share upon vesting. He also reports 91,077 common shares held indirectly by the Russell John Burke Revocable Trust following a transfer of 18,524 directly held shares that was exempt from Section 16 under Rule 16a-13. After the transaction, a fully vested and exercisable stock option covering 419,087 shares of common stock remains outstanding.
Life360, Inc. director Charles J. Prober reported an option exercise and share sale in the company’s stock. On January 13, 2026, he exercised a stock option for 7,930 shares of common stock at an exercise price of $11.18 per share, then sold the same 7,930 shares at a price of $61.98 per share. After these transactions, he directly owned 105,456 shares of common stock, which includes 1,357 restricted stock units that can convert into shares upon vesting, and held 79,300 stock options outstanding.
The filing notes that the transaction was carried out under a Rule 10b5‑1 trading plan adopted on March 14, 2025. This plan is a pre-arranged, automatic trading program that was put in place when the director stated they were not aware of any material nonpublic information about Life360.
Life360, Inc. director reported an insider transaction involving stock options and common shares. On 12/15/2025, the director exercised a stock option to acquire 7,930 shares of common stock at $11.18 per share, then sold 7,930 shares of common stock at $68.3 per share under transaction codes M and S.
After these transactions, the director beneficially owned 105,456 shares of common stock, including 1,357 restricted stock units that each convert into one share upon vesting, and held 87,230 stock options at an exercise price of $11.18 per share. The filing states the trades were made under a pre-established Rule 10b5-1 trading plan adopted on March 14, 2025, and also corrects previously misreported vesting terms for the stock option.
Life360, Inc. Chief Financial Officer Russell John Burke reported an option exercise and related share holdings update. On 12/15/2025, he exercised a stock option to buy 2,500 shares of Life360 common stock at an exercise price of $3.58 per share, classified as transaction code "M". Following this transaction, he beneficially owned 90,754 shares directly and 72,553 shares indirectly through the Russell John Burke Revocable Trust.
The directly held amount includes 72,230 restricted stock units, each representing a contingent right to receive one share of common stock upon vesting. After the exercise, Burke also held 431,514 stock options directly, and the reported option is noted as fully vested and exercisable with an expiration date of 05/19/2030.
Life360, Inc. director John Coghlan reported an insider transaction involving stock options and common stock. On 12/12/2025, he acquired 920 shares of common stock through the exercise of a stock option with an exercise price of $2.15, reflected with transaction code "M".
After the transaction, he beneficially owns 2,592 shares directly, plus 10,737 shares held by the John Coghlan Living Trust and 55,494 shares held by The John Philip Coghlan 2025 Grantor Retained Annuity Trust. His derivative holdings include 142,306 stock options. The footnotes state that 1,672 directly held shares were transferred to the John Coghlan Living Trust under an exemption, that 2,592 direct holdings include 1,672 restricted stock units, and that the reported stock option is fully vested and exercisable.
Life360, Inc. director John Coghlan reported sales, transfers and a charitable gift of company common stock. On 12/05/2025, the John Coghlan Living Trust sold 2,025 shares at a weighted average price of $76.82 and 1,100 shares at a weighted average price of $77.96, in each case under a Rule 10b5-1 trading plan adopted on December 6, 2024.
On 12/09/2025, he made a bona fide gift of 3,045 shares to a donor-advised fund for charitable purposes and transferred 3,045 shares between the John Coghlan Living Trust and The John Philip Coghlan 2025 Grantor Retained Annuity Trust in transactions described as exempt under Rule 16a-13.
Following these transactions, he beneficially owns 3,344 shares directly, 9,065 shares through the John Coghlan Living Trust and 55,494 shares through The John Philip Coghlan 2025 Grantor Retained Annuity Trust, including 1,672 restricted stock units that each represent one share upon vesting.
Life360, Inc.'s Chief Financial Officer reported a tax-related share withholding. On 12/04/2025, the issuer withheld 9,978 shares of common stock at $75.02 per share to satisfy income tax withholding and remittance obligations arising from the vesting and net settlement of previously granted restricted stock units, rather than an open-market sale.
After this transaction, the officer beneficially owned 88,254 shares of Life360 common stock directly and 72,553 shares indirectly through the Russell John Burke Revocable Trust. These holdings also include 72,230 restricted stock units previously granted, each representing a contingent right to receive one share of common stock upon vesting.
Life360, Inc. reported that one of its directors sold common stock in the company. On 12/03/2025, the director sold 15,000 shares of Life360 common stock at a weighted average price of $74.19 per share, with individual trade prices ranging from $74.13 to $74.46. After this transaction, the director beneficially owns 56,809 shares indirectly through the Goines Wong Living Trust and 6,070 shares directly. The direct holdings include 2,339 restricted stock units, each representing the right to receive one share of common stock upon vesting.
Life360, Inc. (LIF) CEO and director reports a small stock sale under a preset trading plan. On 11/24/2025, the reporting person sold 4,546 shares of Life360 common stock at a price of $76.1 per share, coded as an "S" transaction. This sale was made pursuant to a Rule 10b5-1 trading plan adopted on November 27, 2024, which provides for automatic sales based on predetermined criteria and was put in place when the insider was not aware of material nonpublic information.
After this transaction, the insider beneficially owns 324,827 shares of Life360 common stock, including 222,277 restricted stock units that each represent a contingent right to receive one share upon vesting.
Life360, Inc. (LIF) Chief Financial Officer updates holdings and corrects prior option terms. The reporting person exercised a stock option and acquired 6,500 shares of Life360 common stock on 11/19/2025 at an exercise price of $3.58 per share. After the transaction, the reporting person directly held 98,232 common shares and indirectly held 72,553 shares through the Russell John Burke Revocable Trust.
The filing notes that 9,523 directly held shares were previously transferred to the revocable trust under an exemption from Section 16. It also states that 91,732 restricted stock units are included in the beneficial ownership total, each representing a right to receive one common share upon vesting. The stock option underlying this exercise is now fully vested and exercisable, and the vesting terms previously reported for this option were inadvertently misreported and are corrected in this filing.
Life360, Inc. (LIF) reported that one of its directors exercised and sold shares under a pre-arranged trading plan. On 11/13/2025, the director exercised a stock option to acquire 7,930 shares of common stock at $11.18 per share and, on the same date, sold 7,930 shares of common stock at $76.93 per share. After these transactions, the director beneficially owned 105,456 shares of common stock, including 2,036 restricted stock units, and held 95,160 stock options. The filing notes that these trades were executed pursuant to a Rule 10b5-1 trading plan adopted on March 14, 2025, and it corrects the vesting commencement date of the reported stock option to April 1, 2024.
Life360, Inc. (LIF) director John P. Coghlan reported open‑market sales on 11/03/2025 made under a Rule 10b5‑1 trading plan adopted on December 6, 2024. The transactions included 2,866 shares at a weighted average price of $98.88 and 259 shares at a weighted average price of $99.47.
Following the transactions, beneficial ownership reported included 15,235 shares held by the John Coghlan Living Trust, 3,344 shares held directly, and 55,494 shares held by The John Philip Coghlan 2025 Grantor Retained Annuity Trust. Holdings include 2,508 restricted stock units. The filing also notes an exempt transfer of 12,110 shares from the GRAT to the Living Trust pursuant to Rule 16a‑13.
Life360, Inc. (LIF) Chief Executive Officer and Director reported a sale of 4,546 shares of common stock on 10/24/2025 at a price of $93.01 per share, coded “S.” The trade was made pursuant to a Rule 10b5-1 trading plan adopted on November 27, 2024.
Following the transaction, the reporting person beneficially owns 329,373 shares directly. This amount includes 222,277 restricted stock units (RSUs), each representing a contingent right to receive one share upon vesting.
Life360 (LIF) reported an insider transaction: a company director filed a Form 4 for activity on October 13, 2025. The reporting person exercised 7,930 stock options at an exercise price of $11.18 per share and, on the same date, sold 7,930 shares at a price of $103.20 per share. The transactions were executed under a Rule 10b5-1 trading plan adopted on March 14, 2025.
Following these transactions, the reporting person beneficially owned 105,456 shares of common stock. This figure includes 2,036 restricted stock units, each representing a right to receive one share upon vesting. The exercised option relates to a grant with a vesting schedule that began April 12, 2024 and monthly thereafter, and carries an expiration date of April 12, 2028.
John Philip Coghlan, a director of Life360, Inc. (LIF), reported multiple dispositions of common stock effected on 10/01/2025. The filing shows sales under a Rule 10b5-1 trading plan adopted on 12/06/2024. Reported transactions include dispositions of 2,701 shares at a weighted average price of $105.28 (prices ranged $104.84–$105.73), 424 shares at a weighted average of $105.99 (range $105.84–$106.05), and 3,344 shares (note: includes 2,508 restricted stock units) with beneficial ownership changes reported as indirect holdings in the John Coghlan Living Trust and the John Philip Coghlan 2025 Grantor Retained Annuity Trust. The Form 4 was signed by an attorney-in-fact on 10/03/2025.
Life360 insider sale under pre-set plan Lauren Antonoff, who serves as Chief Executive Officer and a director of Life360, Inc. (LIF), reported the sale of 4,546 shares of the company's common stock on 09/24/2025 at a price of $101.52 per share. The filing states the sale was executed under a Rule 10b5-1 trading plan adopted on November 27, 2024, which the reporting person says was established when they were not aware of any material nonpublic information.
The Form 4 shows the reporting person beneficially owns 333,919 shares following the transaction, which includes 222,277 restricted stock units that convert to common shares upon vesting. The form is signed by an attorney-in-fact and provides the required disclosure of relationship and transaction details.
Charles J. Prober, a director of Life360, Inc. (LIF), reported transactions on 09/15/2025 conducted under a Rule 10b5-1 trading plan. The Form 4 shows an acquisition of 7,930 shares via exercise of stock options at an $11.18 exercise price and a contemporaneous sale of 7,930 shares at $100.24 per share. After the transactions the reporting person’s direct beneficial ownership is reported as 105,456 shares in one line and 111,020 options-related shares in the derivative table; the filing also notes total holdings include 2,036 restricted stock units that convert to common stock upon vesting. The Form 4 states the 10b5-1 plan was adopted on March 14, 2025, and the option vesting schedule is described in the filing.